HHM Wealth Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.09K Hold
30
﹤0.01% 753
2026
Q1
$3.54K Hold
30
﹤0.01% 756
2025
Q4
$4.92K Hold
30
﹤0.01% 706
2025
Q3
$4.01K Hold
30
﹤0.01% 747
2025
Q2
$3.73K Hold
30
﹤0.01% 714
2025
Q1
$3.82K Hold
30
﹤0.01% 697
2024
Q4
$4.32K Hold
30
﹤0.01% 692
2024
Q3
$4.46K Hold
30
﹤0.01% 669
2024
Q2
$3.78K Hold
30
﹤0.01% 660
2024
Q1
$5.52K Hold
30
﹤0.01% 619
2023
Q4
$5.39K Hold
30
﹤0.01% 620
2023
Q3
$4.77K Hold
30
﹤0.01% 639
2023
Q2
$4.24K Hold
30
﹤0.01% 676
2023
Q1
$5.05K Hold
30
﹤0.01% 639
2022
Q4
$5.08K Hold
30
﹤0.01% 532
2022
Q3
$6K Hold
30
﹤0.01% 511
2022
Q2
$5K Sell
30
-25
-45% -$3.95K ﹤0.01% 648
2022
Q1
$10K Hold
55
﹤0.01% 541
2021
Q4
$15K Buy
55
+30
+120% +$8.08K ﹤0.01% 474
2021
Q3
$7K Hold
25
﹤0.01% 527
2021
Q2
$5K Buy
+25
New +$4.85K ﹤0.01% 532

Other funds holding RGEN

HHM Wealth Advisors's RGEN Position: Q2 2026 in Review

HHM Wealth Advisors held its Repligen (RGEN) position steady in Q2 2026 at 30 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #753.

HHM Wealth Advisors first reported a position in RGEN in Q2 2021 and has held it in 21 quarters since. The position peaked at $15K in Q4 2021. 48 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • HHM Wealth Advisors held 30 shares of Repligen worth $4.09K as of Q2 2026.
  • HHM Wealth Advisors left its Repligen share count unchanged in Q2 2026.
  • Repligen made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #753 holding.
  • HHM Wealth Advisors first reported a position in Repligen in Q2 2021 and has held it in 21 quarters since.
  • HHM Wealth Advisors's Repligen position peaked at $15K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.